Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,898.00 GBX | +0.35% | -3.33% | +12.25% |
Sep. 18 | European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August | MT |
Sep. 18 | AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment | MT |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
243B | ||||||
816B | ||||||
583B | ||||||
402B | ||||||
342B | ||||||
300B |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Sector Chart